Altimmune (NASDAQ:ALT) Earns Market Perform Rating from Analysts at William Blair
William Blair began coverage on shares of Altimmune (NASDAQ:ALT – Free Report) in a research note issued to investors on Friday morning, Marketbeat Ratings reports. The brokerage issued a market perform rating on the stock. ALT has been the topic of a number of other research reports. UBS Group initiated coverage on Altimmune in a […]
William Blair began coverage on shares of Altimmune (NASDAQ:ALT – Free Report) in a research note issued to investors on Friday morning, Marketbeat Ratings reports. The brokerage issued a market perform rating on the stock. ALT has been the topic of a number of other research reports. UBS Group initiated coverage on Altimmune in a […]
